Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.
Okada Y, Sato K, Kobayashi S, Nagao S, Takano K, Teramoto M, Tachi N, Kawamura T, Horiuchi T, Kato S, Saga R, Maekawa T, Yamamura T, Watanabe J, Kobayashi A, Kimura F.
Okada Y, et al. Among authors: kobayashi a, kobayashi s.
Int J Hematol. 2018 Apr;107(4):495-497. doi: 10.1007/s12185-017-2354-6. Epub 2017 Oct 14.
Int J Hematol. 2018.
PMID: 29032513